Meyer FSMP Hong Kong Secures NMPA Approval for First FSMP in Greater China

Meyer FSMP Hong Kong Secures NMPA Approval for First FSMP in Greater China

Hong Kong-based Meyer FSMP Hong Kong Limited, an oncology-focused foods for special medical purpose (FSMP) company, announced it has received marketing approval from China’s National Medical Products Administration (NMPA) for its carbohydrate component formula. The product is the first FSMP approved in the Hong Kong, Macao, and Taiwan regions.

Product Details
The approved FSMP is designed for individuals aged 10 and older requiring carbohydrate supplementation due to specific diseases or medical conditions. Consumption guidelines, including dosage, are determined by doctors or clinical nutritionists based on the patient’s age, weight, and health status.

FSMP Significance
FSMP products are specially formulated for people with eating restrictions, digestive disorders, metabolic issues, or specific illnesses. They must be used under medical supervision. Meyer, which has developed and promoted such products since 2016, overcame cross-border regulatory hurdles with this approval, paving the way for broader FSMP registration in China.-Fineline Info & Tech

Leave a Reply

Your email address will not be published. Required fields are marked *

Insight, China's Pharmaceutical Industry